Why is the Polynovo share price rocketing 17%?

Could more insider buying be behind Polynovo's Tuesday gains?

| More on:
A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The Polynovo share price launched 21.5% to its intraday high of $1.13 on Tuesday
  • Its gain came amid more news of insider buying at the company after an entity owned by its chair forked out $227,500 on-market yesterday
  • The surge is bad news for short-sellers targeting Polynovo with the company one of the most shorted on the ASX 

The Polynovo Ltd (ASX: PNV) share price is taking off on Tuesday despite the broader market's downturn.

At the time of writing, the Polynovo share price is $1.09, 17.2% higher than its previous close. Additionally, the medical device company's chair has snapped up another parcel of Polynovo shares.

For context, the All Ordinaries Index (ASX: XAO) and the S&P/ASX 200 Index (ASX: XJO) are both down around 1.3% right now. That marks a slight recovery after the indexes both hit a three-month low this morning.

Let's take a closer look at what might be going on with the Polynovo share price today.

What's going on with Polynovo today?

The Polynovo share price is surging 17% today amid more news of insider buying.

An entity owned by the company's chair David Williams splashed out yesterday, snapping up $227,500 worth of Polynovo stock on the market.

The purchase saw the entity taking home 250,000 shares at a cost of 91 cents apiece. Thus, they're already bringing a 19.8% return on investment.

That – and the 1.5 million shares Williams purchased last week – has brought his holding in the company to 20.65 million shares.

Additionally, another two of the company's directors reported buying into its stock last week, each snapping up parcels of 100,000 shares.

That might suggest insiders believe the Polynovo share price recently bottomed out.

Today's gains see the medical device company's stock surpassing $1 for the first time in nearly two months. That's a win for investors, but it might be disappointing news for those shorting the stock.

The most recent data available shows 10% of Polynovo shares are in the hands of short-sellers, making it the fifth most shorted stock on the ASX, according to The Motley Fool Australia's latest weekly short-selling breakdown.

Polynovo share price snapshot

Despite today's surge, Polynovo's shares are still trading for 29% less than what they were at the start of 2022.

They have also fallen 60% since this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Guess which ASX healthcare stock is jumping 12% on Wednesday

This shares is rocketing this morning. But why? Let's find out.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Healthcare Shares

Here is the dividend forecast to 2029 for CSL shares

Can this blue-chip giant provide healthy dividend income?

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

The best ASX 200 healthcare stocks to buy in 2025

These shares could give your portfolio a healthy boost next year according to Bell Potter.

Read more »

In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
Healthcare Shares

ASX 300 healthcare stock lifts off on promising new results

Up 28% in a year, the ASX healthcare stock is leaping higher on Thursday.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

If you'd invested $5,000 in this ASX 300 healthcare stock a year ago, you'd now have $30,000!

This stock has made millions for investors over just a few months.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

Has the Pro Medicus share price risen too high too quickly?

Pro Medicus shares have rocketed 173% since this time last year.

Read more »